Glenn S Boehnlein Stryker Corp (SYK) insider trading activity

Glenn S Boehnlein is VP, Chief Financial Officer of STRYKER CORP. Currently has a direct ownership of 4,373 shares of SYK, which is worth approximately $1.61 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 2,979 shares (Common Stock) at a price of $390.08 per share, resulting in proceeds of $1,162,048. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.37K

53.33% 3M change

51.28% 12M change

Total Value Held $1.61 Million

Glenn S Boehnlein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Payment of exercise price or tax liability	$1,162,048 $390.08 p/Share	2,979 Reduced 40.52%	4,373 Common Stock
Nov 18 2024	BUY Exercise of conversion of derivative security	$551,295 $122.51 p/Share	4,500 Added 37.97%	7,352 Common Stock
Aug 02 2024	SELL Open market or private sale	$6,660,000 $333.0 p/Share	20,000 Reduced 87.52%	2,852 Common Stock
Jul 02 2024	SELL Payment of exercise price or tax liability	$5,774,340 $336.5 p/Share	17,160 Reduced 42.89%	22,852 Common Stock
Jul 02 2024	BUY Exercise of conversion of derivative security	$3,062,750 $122.51 p/Share	25,000 Added 38.45%	40,012 Common Stock
May 15 2024	SELL Open market or private sale	$3,276,500 $327.65 p/Share	10,000 Reduced 39.98%	15,012 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$196,852 $336.5 p/Share	585 Reduced 2.29%	25,012 Common Stock
Mar 21 2024	SELL Payment of exercise price or tax liability	$1,961,970 $353.19 p/Share	5,555 Reduced 17.83%	25,597 Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	-	256 Added 0.82%	31,152 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	10,702 Added 25.73%	30,896 Common Stock
Feb 09 2024	SELL Open market or private sale	$3,290,976 $342.81 p/Share	9,600 Reduced 32.22%	20,194 Common Stock
Jan 11 2024	SELL Payment of exercise price or tax liability	$12,060,974 $307.78 p/Share	39,187 Reduced 56.81%	29,794 Common Stock
Jan 11 2024	BUY Exercise of conversion of derivative security	$5,691,474 $94.85 p/Share	60,005 Added 46.52%	68,981 Common Stock
Nov 27 2023	SELL Payment of exercise price or tax liability	$2,229,902 $293.64 p/Share	7,594 Reduced 45.83%	8,976 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	$970,028 $81.14 p/Share	11,955 Added 41.91%	16,570 Common Stock
May 01 2023	SELL Payment of exercise price or tax liability	$171,399 $299.65 p/Share	572 Reduced 11.03%	4,615 Common Stock
Mar 21 2023	SELL Payment of exercise price or tax liability	$751,593 $276.83 p/Share	2,715 Reduced 34.36%	5,187 Common Stock
Mar 21 2023	BUY Exercise of conversion of derivative security	-	149 Added 1.85%	7,902 Common Stock
Mar 07 2023	BUY Grant, award, or other acquisition	-	5,325 Added 40.72%	7,753 Common Stock
Feb 02 2023	SELL Open market or private sale	$6,810,911 $278.85 p/Share	24,425 Reduced 90.96%	2,428 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$2,224,709 $263.81 p/Share	8,433 Reduced 23.9%	26,853 Common Stock
Jan 11 2023	BUY Exercise of conversion of derivative security	$929,105 $64.01 p/Share	14,515 Added 29.15%	35,286 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$138,001 $241.26 p/Share	572 Reduced 3.02%	18,350 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	1,210 Added 6.01%	18,922 Common Stock
Mar 21 2022	SELL Payment of exercise price or tax liability	$1,100,371 $267.34 p/Share	4,116 Reduced 18.86%	17,712 Common Stock

Also insider at

INGN

Inogen Inc Healthcare

GSB